Nav: Home

Current Vaccine News and Events

Current Vaccine News and Events, Vaccine News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Intranasal vaccine platform has potential for more effective vaccines, fewer side effects
The ongoing COVID-19 pandemic is shining a spotlight on vaccine development. (2020-08-07)
BCG vaccine is safe and does not lead to an increased risk of COVID-19 symptoms
The BCG vaccine, an vaccine originally made against tuberculosis, has a general stimulating effect on the immune system and is therefore effective against multiple infectious diseases - possibly also against COVID-19. (2020-08-06)
NIH-Moderna investigational COVID-19 vaccine shows promise in mouse studies
The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COVID-19, according to research published today in Nature. (2020-08-05)
Locking down shape-shifting spike protein aids development of COVID-19 vaccine
Publishing in the journal Nature, researchers from the Univ. of Texas at Austin, Moderna and the NIH explain how they developed the COVID-19 vaccine candidate mRNA-1273 and report strong positive results on its effectiveness in mice. (2020-08-05)
The six strains of SARS-CoV-2
SARS-CoV-2 mutation rate remains low. Across Europe and Italy, the most widespread is strain G, while the L strain from Wuhan is gradually disappearing. (2020-08-03)
RSV vaccination of pregnant women could prevent pneumonia in babies
Professor Shabir A. Madhi of the University of the Witwatersrand, Johannesburg, is the lead author of a study published in the prestigious New England Journal of Medicine on Thursday, 30 July 2020. (2020-08-01)
Investigational breast cancer vaccine plus immune therapy work well in tandem
A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at Duke Cancer Institute is part of an effective, two-drug strategy for enlisting the immune system to fight tumors, according to a Duke-led study in Clinical Cancer Research, a journal of the American Association for Cancer Research. (2020-07-30)
Single-shot COVID-19 vaccine protects non-human primates
A leading COVID-19 vaccine candidate, developed at Beth Israel Deaconess Medical Center, creates the groundwork for a newly launched COVID-19 vaccine clinical trial. (2020-07-30)
Presenting a SARS-CoV-2 mouse model to study viral responses and vaccine candidates
Researchers who generated a strain of SARS-CoV-2 that can infect mice used it to produce a new mouse model of infection that may help facilitate testing of COVID-19 vaccines and therapeutics. (2020-07-30)
Slowing down a 'helper' cell may someday make vaccines more effective for seniors
Suppressing IL-10 production from 'Tfh 10' cells within the immune systems of older people could make influenza vaccines more effective, according to new research led by experts from Cincinnati Children's. (2020-07-29)
Iron deficiency during infancy reduces vaccine efficacy
About 40 percent of children around the globe suffer from anaemia because they do not consume enough iron. (2020-07-28)
Experimental COVID-19 vaccine protects upper and lower airways in nonhuman primates
Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2, report scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. (2020-07-28)
Flu, pneumonia vaccinations tied to lower risk of Alzheimer's dementia
Flu (influenza) and pneumonia vaccinations are associated with reduced risk of Alzheimer's disease, according to new research reported at the Alzheimer's Association International Conference® (AAIC®) 2020. (2020-07-27)
SMART finds new and safe method that enhances dengue vaccination -- Paving way to wide use
Researchers at SMART have discovered a practical way to induce strong and broad immunity to the dengue virus. (2020-07-27)
Flu vaccine may reduce risk of Alzheimer's disease, new study shows
People who received at least one flu vaccination were 17% less likely to get Alzheimer's disease over the course of a lifetime, according to researchers at UTHealth. (2020-07-27)
Flu vaccine could protect against serious heart and stroke complications
The rate of seasonal flu vaccinations among people over age 50 and nursing home residents is extremely low, and those who do get the flu vaccine can significantly lower their risk of heart attack, TIA (transient ischemic attack), death and cardiac arrest. (2020-07-27)
New affinity purification technique for therapeutic proteins
Professor Kimoon Kim's research group at POSTECH has developed a highly pure and efficient technique for purifying antiviral and anti-cancer protein therapeutics using molecular affinity interaction. (2020-07-27)
UCalgary researchers unlock new insights that could help with vaccine development
Researchers at the University of Calgary have unlocked new insights that may help with vaccine development for infectious diseases such as COVID-19, malaria, and tuberculosis. (2020-07-27)
T cells can shift from helping to harming in atherosclerosis
At La Jolla Institute for Immunology (LJI) researchers are dedicated to finding a way to stop plaques from forming in the first place. (2020-07-24)
Another mRNA-based vaccine candidate protects animals against SARS-CoV-2
An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice and non-human primates, researchers report on July 23rd in the journal Cell. (2020-07-24)
COVID-19 vaccine innovation could dramatically speed up worldwide production
A new modified version of the SARS-CoV-2 spike protein has a 10-fold higher expression rate in cell cultures than an earlier version that forms the basis of vaccine candidates currently in clinical trials from Moderna and Novavax. (2020-07-23)
Engineered SARS-CoV-2 protein offers better stability and yields for vaccine researchers
A team of scientists has engineered the spike protein of the SARS-CoV-2 virus - a critical component of potential COVID-19 vaccines - to be more environmentally stable and generate larger yields in the lab. (2020-07-23)
We are mutating SARS-CoV-2, but it is evolving back
Scientists at the Milner Centre for Evolution looked at the evolution of the virus that causes Covid19; their findings could help the design of a new vaccine. (2020-07-22)
Scientists present pre- and postfusion cryo-em structures of SARS-CoV-2 spike protein
Scientists report two new cryo-EM structures representing the pre- and postfusion conformations of the full-length SARS-CoV-2 spike (S) protein, an essential viral component responsible for host cell entry and the spread of infection. (2020-07-21)
Parents of 1 in 2 unvaccinated US adolescents have no intention to initiate HPV vaccine
Study results documenting parental hesitancy to begin and complete their child's HPV vaccine series were published in The Lancet Public Health by researchers at The University of Texas Health Science Center at Houston (UTHealth). (2020-07-21)
The Lancet: UK's vaccine against SARS-CoV-2 is safe and induces an immune reaction
UK's vaccine against SARS-CoV-2 is safe and induces an immune reaction, according to preliminary results. (2020-07-20)
The Lancet: Chinese phase 2 trial finds vaccine is safe and induces an immune response
Chinese phase 2 trial finds vaccine is safe and induces an immune response. (2020-07-20)
COVID-19 replicating RNA vaccine has robust response in nonhuman primates
A replicating RNA vaccine, formulated with a lipid-based nanoparticle emulsion, produces antibodies against the COVID-19 coronavirus in mice and primates with a single immunization. (2020-07-20)
A nanoparticle vaccine for SARS-CoV-2 produces signs of immunity in mice and macaques
A new nanoparticle vaccine for SARS-CoV-2, the virus that causes COVID-19, has shown hints of protection and immunity in a preclinical study, safely eliciting the production of antibodies and antiviral T cell responses in mice and pigtail macaques. (2020-07-20)
Scientists trace and identify origin of smallpox vaccine strains used in Civil War
Scientists and historians working at McMaster University, the Mütter Museum and the University of Sydney have pieced together the genomes of old viruses that were used as vaccination strains during and after the American Civil War ultimately leading to the eradication of smallpox. (2020-07-19)
Un-natural mRNAs modified with sulfur atoms boost efficient protein synthesis
A group of Japanese scientists has succeeded in the development of modified messenger RNAs (mRNAs) that contain sulfur atoms in the place of oxygen atoms of phosphate moieties of natural mRNAs. (2020-07-16)
Scientists uncover SARS-CoV-2-specific T cell immunity in recovered COVID-19 and SARS patients
The T cells, along with antibodies, are an integral part of the human immune response against viral infections due to their ability to directly target and kill infected cells. (2020-07-16)
Vaccine additives can enhance immune flexibility -- Implications for flu and SARS-CoV-2
A vaccine additive known as an adjuvant can enhance responses to a vaccine containing the exotic avian flu virus H5N1, so that both rookie and veteran elements of the immune response are strengthened, according to results from an Emory Vaccine Center study. (2020-07-16)
Mouse model of contained tuberculosis infection could lead to a more effective vaccine
A novel mouse model of the protective effects of contained tuberculous infection could lead to the development of a more effective vaccine, according to a study published July 16 in the open-access journal PLOS Pathogens by Alan Diercks of Seattle Children's Research Institute, and colleagues. (2020-07-16)
Aging-associated inflammation may worsen COVID-19 outcomes in older individuals
The increased severity and mortality of SARS-CoV-2 infections in older individuals may be related to inflammageing -- an age-associated phenomenon of increased general inflammation. (2020-07-16)
A nanomaterial path forward for COVID-19 vaccine development
From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines. (2020-07-15)
Experimental COVID-19 vaccine safe, generates immune response
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes COVID-19, was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published today in The New England Journal of Medicine. (2020-07-14)
Scientists discover key element of strong antibody response to COVID-19
A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19. (2020-07-13)
Studying nearly 300 recently identified antibodies to SARS-CoV-2 reveals a common theme
An analysis of nearly 300 recently identified human SARS-CoV-2 antibodies uncovered a gene frequently used in antibodies that most effectively target the virus. (2020-07-13)
Breakthrough with cancer vaccine
Scientists have developed a new cancer vaccine with the potential to activate the body's immune system to fight a range of cancers, including leukaemia, breast cancer, lung cancer and pancreatic cancers. (2020-07-09)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Our Relationship With Water
We need water to live. But with rising seas and so many lacking clean water – water is in crisis and so are we. This hour, TED speakers explore ideas around restoring our relationship with water. Guests on the show include legal scholar Kelsey Leonard, artist LaToya Ruby Frazier, and community organizer Colette Pichon Battle.
Now Playing: Science for the People

#568 Poker Face Psychology
Anyone who's seen pop culture depictions of poker might think statistics and math is the only way to get ahead. But no, there's psychology too. Author Maria Konnikova took her Ph.D. in psychology to the poker table, and turned out to be good. So good, she went pro in poker, and learned all about her own biases on the way. We're talking about her new book "The Biggest Bluff: How I Learned to Pay Attention, Master Myself, and Win".
Now Playing: Radiolab

Uncounted
First things first: our very own Latif Nasser has an exciting new show on Netflix. He talks to Jad about the hidden forces of the world that connect us all. Then, with an eye on the upcoming election, we take a look back: at two pieces from More Perfect Season 3 about Constitutional amendments that determine who gets to vote. Former Radiolab producer Julia Longoria takes us to Washington, D.C. The capital is at the heart of our democracy, but it's not a state, and it wasn't until the 23rd Amendment that its people got the right to vote for president. But that still left DC without full representation in Congress; D.C. sends a "non-voting delegate" to the House. Julia profiles that delegate, Congresswoman Eleanor Holmes Norton, and her unique approach to fighting for power in a virtually powerless role. Second, Radiolab producer Sarah Qari looks at a current fight to lower the US voting age to 16 that harkens back to the fight for the 26th Amendment in the 1960s. Eighteen-year-olds at the time argued that if they were old enough to be drafted to fight in the War, they were old enough to have a voice in our democracy. But what about today, when even younger Americans are finding themselves at the center of national political debates? Does it mean we should lower the voting age even further? This episode was reported and produced by Julia Longoria and Sarah Qari. Check out Latif Nasser's new Netflix show Connected here. Support Radiolab today at Radiolab.org/donate.